Abstract:A flexible class of Ni(II) and Zn(II) complexes were prepared with a novel Schiff base ligand containing imidazole moiety. The synthesized compounds were taken for structural characterizations such as elemental analysis, UV-Vis, FT-IR, 1H and 13C NMR, mass spectra, thermogravimetric investigation, magnetic susceptibility, and conductivity estimations. The coordination building of Ni(II) and Zn(II) complexes were found as octahedral and tetrahedral where Ni(II) and Zn(II) metal ions were composed by a nitrogen atom of the azomethine, imidazole ring, and oxygen atom of acetate derivative. All of the synthesized compounds were tried for their biochemical properties, including antioxidant, anti-inflammatory, antimicrobial activities, enzyme inhibition, and cytotoxicity. The antioxidant activity of designed compounds was screened by the 1,1-diphenyl-2-picrylhydrazyl (DPPH) technique and all the Schiff base ligand and some of its Ni(II)/Zn(II) complexes showed close antioxidant activities against the standards (BHA, BHT, and ascorbic acid). Anti-inflammatory activity was estimated by the in-vitro human red blood cell (HRBC) membrane stabilization method, the Zn(II) complexes exhibited more activity for inflammation compared with Diclofenac, which is used as a standard drug. The in-vitro antimicrobial movement of synthesized compounds have been examined in microorganisms like Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, Staphylococcus aureus, Streptococcus mutans, Enterobacter cloacae, Aspergillus niger and Candida albicans by agar disk diffusion method. Nystatin and Ciprofloxacin were selected as reference drugs. Enzyme inhibitions of the Schiff bases and their metal complexes were investigated using α-amylase and the best inhibition value (Ki) was observed for the Ni(II)/Zn(II) complex of 4-[(5-methyl-3H-imidazole-4-ylmethylene)-amino]-2-nitro-phenol (MINPN/MINPZ) (0.022/0.020 mM) with Acarbose as standard compound. The cytotoxic behavior of synthesized compounds was evaluated against cancer cell lines: DLA cells (Trypan blue exclusion method) and HepG2 cells (MTT assay) and determined the cell viability of the respective human cell, H9c2 via MTT assay. Encouragingly, most of the compounds are generally non-toxic, to the human cells, H9c2.

Synthesis, characterization, biological activity of Schiff bases derived from 3-bromo-4-methyl aniline and its potentiometric studies with Cu(II), Co(II) and Ni(II) ions

SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL ACTIVITIES OF Ni(II) AND Cu(II) COMPLEXES WITH SCHIFF BASE DERIVED FROM 2-ACETYL-5-METHYLFURAN GLYOXIME HYDRAZONE

Synthesis, Spectral Characterization, Antimicrobial Activity, DFT Calculations, Molecular Docking and ADME Studies of Novel Schiff Base Co(II), Ni(II), Cu(II) and Zn(II) Complexes Derived from 4‐nitro‐ortho‐phenylenediamine

Synthesis, spectro-themal characterization, DFT calculations and biochemical evaluation of a newly synthesized tridentate Schiff base transition metal complexes

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Novel Schiff base (E)-2-((4-chloro-3-nitrophenylimino)(phenyl)methyl)-5-methoxyphenol and Mixed Ligand Complexes of Mn(II), Fe(III), Co(II), Ni(II) and Cu(II): synthesis, structure elucidation and potency study as antibacterial, antimalarial, antioxidant, antidibetic and anticancer agents

Synthesis, characterization and anti-bacterial activity of novel schiff bases of pyridin-3 yl-carbohydrazide derivatives

Syntheses, characterizations, X-ray crystal structures, and antibacterial activities of Co(II), Ni(II), and Zn(II) complexes of the Schiff base derived from 5-nitro-2-hydroxybenzaldehyde and benzylamine

Three Co(II), Ni(II) and Cu(II) Schiff base complexes incorporating 2-[(4-{[(4-methylphenyl)sulfonothioyl]oxy}phenyl)methylene] amino}benzoic acid: Synthesis, structural, dft, biological and molecular docking investigation

Synthesis, Structural and Antimicrobial Studies of Transition Metal Complexes of a Novel Schiff Base Ligand Incorporating 1,2,4-Triazole and 4-(Benzyloxy)benzaldehyde Moieties

Synthesis, Characterization, Investigation of DNA Interactions and Biological Evaluation of Co(II), Ni(II), Cu(II) and Zn(II) Complexes with Newly Synthesized 2-methoxy 5-trifluoromethyl benzenamine Schiff Base

Biological and electrochemical studies of Co2+, Ni2+, Cu2+, Zn2+ and Cd2+ metal complexes of Schiff base ligand derived from 4-amino benzoic acid and isonicotinic hydrazide

Synthesis and Spectroscopic Characterization of Schiff Base Metal Complexes, Biological Activity, and Molecular Docking Studies

SYNTHESIS, CHARACTRIZATION AND ANTIBACTERIAL ACTIVITY OF SCHIFF BASES DERIVED FROM PHENYL HYDRAZINE DERIVATIVES AND THEIR Cu (II) and Zn (II) COMPLEXES

Transition metal complexes of imidazole derived Schiff bases: Antioxidant/anti-inflammatory/antimicrobial/enzyme inhibition and cytotoxicity properties

Synthesis, spectral studies and antimicrobial evaluation of transition metal complexes of bidentate Schiff base ligands derived from 4-amino quinoline

Anion Induced Synthesis and Crystal Structures of Schiff Base Copper(II) and Zinc(II) Complexes with Antibacterial Activity

Exploration on Synthesis, Characterization and Biological Activities of Transition Metal Complexes Comprising Hydroxybenzylideneaminocyclohexylimino-methyl-4,6-dibromophenol Schiff Base Ligand

Synthesis, characterization, biological (in vitro) activity, spectral and electrochemical behavior of N, S donors Schiff base ligand and their mixed-ligand copper (II)/cobalt (II) complexes with 5, 5’-dimethyl-2, 2’-bipyridine and 1, 10-phenanthroline

Synthesis of Novel 2-Amino Thiazole Derivatives and Salicyaldehyde based Ligand to have Biological Activity

Synthesis, structural elucidation, molecular modeling and antimicrobial studies of Mn(II), Co(II), Ni(II), and Cu(II) complexes containing NO donor bidentate Schiff base